UPDATE | July 2, 2020

Samsung Biologics Presents Virtually at Annual Biologics Manufacturing Asia

  • MAIL

virtually participating at the 7th Annual Biologics Manufacturing Asia, which is held online this year from 7th to 8th of July


  

 

Samsung Biologics will be virtually participating at the 7th Annual Biologics Manufacturing Asia, which is held online this year from 7th to 8th of July. As the largest and only bioprocess business and technology convention in the Asia-Pacific, more than 500 biomanufacturing stakeholders from the industry will be attending this year.  

 

The convention will focus on three main agendas: Cell therapy manufacutring and supply chain, Bio-analytics, Bio-manufacturing.

 

There will be 2 speakers from Samsung Biologics, presenting at two different live stream sessions. VP Yongho Ahn, Head of CDO R&D Team will discuss studies on "A Strategy for Minimizing Lactate and pCO2 Accumulation in CHO Cell Culture Process" on July 7th at 11:40AM. SeungSun Lee, Director of DS USP will also present on July 7th at 14:20PM to talk about "Application of Large Scale N-1 Bioreactor Perfusion". These sessions will last 25minutes each. 

 

To learn more, join our live stream sessions at the 7th Annual Biologics Manufacturing Asia. 

Biologics Manufacturing Asia website  

virtually participating at the 7th Annual Biologics Manufacturing Asia, which is held online this year from 7th to 8th of July


  

 

Samsung Biologics will be virtually participating at the 7th Annual Biologics Manufacturing Asia, which is held online this year from 7th to 8th of July. As the largest and only bioprocess business and technology convention in the Asia-Pacific, more than 500 biomanufacturing stakeholders from the industry will be attending this year.  

 

The convention will focus on three main agendas: Cell therapy manufacutring and supply chain, Bio-analytics, Bio-manufacturing.

 

There will be 2 speakers from Samsung Biologics, presenting at two different live stream sessions. VP Yongho Ahn, Head of CDO R&D Team will discuss studies on "A Strategy for Minimizing Lactate and pCO2 Accumulation in CHO Cell Culture Process" on July 7th at 11:40AM. SeungSun Lee, Director of DS USP will also present on July 7th at 14:20PM to talk about "Application of Large Scale N-1 Bioreactor Perfusion". These sessions will last 25minutes each. 

 

To learn more, join our live stream sessions at the 7th Annual Biologics Manufacturing Asia. 

Biologics Manufacturing Asia website  

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required